Anthony Letai was Named as the New Director of NIH's National Cancer Institute

Anthony Letai

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 influential women in oncology

The Royal College of Radiologists 2024 Report: Radiology Lag, Oncology Delays

The Royal College of Radiologists

Elizabeth Whittington: Grateful to Witness St. Jude’s Global Mission at the United Nations

Elizabeth Whittington

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Tedros Adhanom Ghebreyesus: Thanks to World Leaders for Showing Strong Support for UNGA Political Declaration

UNGA

Jonathan Friedberg: PROs vs Clinician-reported Adverse Events in a Large Clinical Trial

Friedberg Jonathan

Naveen Pemmaraju: Omacetaxine + VEN in Patients with R/R MDS/AML with RUNX1 Mutation

Naveen Pemmaraju, BPDCN

OncoCalendar

« All Events

  • This event has passed.

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

Dec 16, 2024 • 7:00 PM - 9:00 PM
SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC will be held on December 16th, 2024.

This exclusive course will offer the latest updates on lung cancer treatment in Southeast Asia, with a special focus on immunotherapy. In Series II, renowned thoracic oncology experts from the region will delve into the role of immunotherapy in revolutionizing lung cancer care. Discussions will cover crucial topics such as the integration of biomarkers for immunotherapy, the best management strategies for advanced disease, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy is set to transform the landscape of lung cancer treatment in Southeast Asia, bringing hope for improved patient outcomes.

See the Speakers and Southeast Asia Team Below:

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

Details

Date:
Dec 16, 2024
Time:
7:00 PM - 9:00 PM
Website:
https://www.iaslc.org/node/35048

Organizer

The International Association for the Study of Lung Cancer (IASLC)
Phone
1-855-464-2752
Email
info@iaslc.org